Financing, Equity Capital Markets
Fulcrum Therapeutics, Inc.
01/23
|
$125.0 Million
![](/sites/default/files/images/custom/fulcrum-therapeutics-inc_0.png)
Piper Sandler served as bookrunner for Fulcrum Therapeutics, Inc. on a confidentially marketed follow-on offering